Diagnostic Imaging for Palpable Breast Masses and Lymphadenopathy

Age-Based Imaging Algorithm

The National Comprehensive Cancer Network recommends obtaining diagnostic mammography (or digital breast tomosynthesis) as the mandatory first imaging study for women ≥30 years old with a visible breast mass and lymphadenopathy, followed by axillary ultrasound at the same visit 1, 2, 3
For women ≥30 years old, the American College of Radiology suggests that the mammogram must include standard mediolateral oblique and craniocaudal views, plus magnification views to identify microcalcifications that may indicate ductal carcinoma in situ (DCIS) 2
The National Comprehensive Cancer Network guidelines state that for women <30 years old, targeted breast ultrasound should be used as the initial imaging study, avoiding unnecessary radiation exposure in this low-risk age group 1, 4

Mammography identifies occult breast cancer in the ipsilateral or contralateral breast that may have metastasized to the axilla, with a detection rate of 9 out of 17 cancer cases in patients with isolated axillary lymphadenopathy 1
The American College of Radiology recommends that mammography provides global assessment of both breasts to detect synchronous cancers that would alter surgical planning 5
Mammography detects microcalcifications associated with the mass that indicate extent of disease and presence of DCIS, which cannot be reliably detected by ultrasound alone 2, 5

The combined negative predictive value of mammography plus ultrasound exceeds 97%, providing comprehensive evaluation, according to the National Comprehensive Cancer Network guidelines 2
The American College of Radiology states that diagnostic mammogram and/or digital breast tomosynthesis complement axillary ultrasound by evaluating the breast for underlying lesions in patients presenting with axillary lymphadenopathy 1, 5

The National Comprehensive Cancer Network recommends that complete all imaging studies (mammography and ultrasound) before proceeding to tissue diagnosis, as biopsy-related changes confuse subsequent image interpretation 2, 4
The American College of Radiology suggests proceeding directly to image-guided core biopsy if imaging shows a correlate, as core biopsy provides superior sensitivity, specificity, and histological grading 2

If core needle biopsy indicates malignancy of breast origin in the axillary lymph node but no breast abnormality is evident with ultrasound or mammogram, the National Comprehensive Cancer Network recommends performing MRI to identify occult primary 1
The American College of Radiology states that MRI detected an occult breast cancer in more than two-thirds of patients with suspicious axillary lymphadenopathy and negative conventional imaging 5